Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1983-2-14
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0098-6151
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
82
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
192-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6294008-Clinical Trials as Topic,
pubmed-meshheading:6294008-Double-Blind Method,
pubmed-meshheading:6294008-Endorphins,
pubmed-meshheading:6294008-Female,
pubmed-meshheading:6294008-Humans,
pubmed-meshheading:6294008-Naloxone,
pubmed-meshheading:6294008-Premenstrual Syndrome,
pubmed-meshheading:6294008-beta-Endorphin
|
pubmed:year |
1982
|
pubmed:articleTitle |
Can increased beta-endorphins explain the etiology of premenstrual syndrome?
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|